High-throughput determination of ivabradine from human plasma by LC/MS/MS and its application to pharmacokinetic studies

Studia Universitatis Babes-Bolyai Chemia

Volumn 2, Issue , 2009, Pages 43-52

  Vlase, Laurian ^a   Muntean, Dana ^a   Leucuţa, Sorin E ^a   Bâldea, Ioan ^b  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b BABE BOLYAI UNIVERSITY   (Romania)

Author keywords

Human plasma; Ivabradine; LC MS MS; Pharmacokinetics

Indexed keywords

EID: 70349213258     PISSN: 12247154     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. J. A. Portoles, A. Terleira, A. Calvo, I. Martinez, G. Resplandy, J. Clin. Pharmacol., 2006, 46, 1188.
2. A. Portoles, A. Calvo, A. Terleira, L. Laredo, G. Resplandy, C. Gorostiaga, A. Moreno, J. Clin. Pharmacol., 2006, 46, 1195.
3. Y. M. Di, C. G. Li, C. C. Xue, S.F. Zhou, Curr. Pharm. Des., 2008, 14(17), 1723.
4. M. Francois-Bouchard, G. Simonin, M. J. Bossant, C. Boursier-Neyret, Journal of Chromatography B, 2000, 745, 261.
5. P. Klippert, J. P. Jeanniot, S. Polve, C. Lefevre, H. Merdjan, Journal of Chromatography B, 1988, 719, 125.
6. The European Agency for the Evaluation of Medicinal Products. Note for Guidance on the Investigation of Bioavailability and Bioequivalence, London, UK, 2001 (CPMP/EWP/QWP/1401/98).
7. U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry. Bioavailability and Bioequivalence Studies for Orally Administrated Drug Products - General Considerations, Rockville, USA, 2003, http://www.fda.gov/cder/guidance/index.htm
8. U. S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry-Bioanalytical Method Validation, 2001.